Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.
Cytoglobin (CYGB) is a recently discovered vertebrate globin distantly related to myoglobin with unknown function. CYGB is assigned to chromosomal region 17q25, which is frequently lost in multiple malignancies. Previous studies failed to detect evidence for mutations in the CYGB gene. Recent studies provided preliminary evidence for increased methylation of the gene in lung cancer. Our study was aimed at investigating the role of CYGB as a tumor suppressor gene. By nested methylation-specific DNA sequencing analysis of lung and breast cancer cell lines and bronchial and mammary epithelial cell lines, we identified that methylation of a 110-bp CpG-rich segment of the CYGB promoter was correlated with gene silencing. We specifically targeted this sequence and developed a quantitative methylation-specific PCR assay, suitable for high-throughput analysis. We showed that the tumor specificity of CYGB methylation in discriminating patients with and without lung cancer, using biopsies and sputum samples. We further showed the tumor specificity of this assay with multiple other epithelial and hematologic malignancies. To show tumor suppressor activity of CYGB, we performed the following: (a) RNA interference-mediated knockdown of CYGB gene on colony formation in a CYGB expression-positive lung cancer cell line, resulting in increased colony formation; (b) enforced gene expression in CYGB expression-negative lung and breast cancer cell lines, reducing colony formation; and (c) identification of potential proximate targets down-stream of the CYGB genes. Our data constitute the first direct functional evidence for CYGB, the newest member of the globin family, as a tumor suppressor gene.
Shivapurkar
Narayan
N
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. Narayan.Shivapurkar@UTSouthwestern.edu
Stastny
Victor
V
Okumura
Naoki
N
Girard
Luc
L
Xie
Yang
Y
Prinsen
Clemens
C
Thunnissen
Frederik B
FB
Wistuba
Ignacio I
II
Czerniak
Bogdan
B
Frenkel
Eugene
E
Roth
Jack A
JA
Liloglou
Triantafillos
T
Xinarianos
George
G
Field
John K
JK
Minna
John D
JD
Gazdar
Adi F
AF
D001943:Breast Neoplasms / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics; D000078842:Cytoglobin; D019175:DNA Methylation; D020869:Gene Expression Profiling; D020868:Gene Silencing; D016147:Genes, Tumor Suppressor; D005914:Globins / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics; D009369:Neoplasms / Q000235:genetics*; D016133:Polymerase Chain Reaction; D014162:Transfection
C000627265:CYGB protein, human; D000078842:Cytoglobin; D005914:Globins
Physiol Genomics. 2007 Aug 20;30(3):335-41
17519360
Hum Mol Genet. 2006 Jul 1;15(13):2038-44
16698880
Int J Cancer. 2005 Feb 10;113(4):600-4
15472908
Gastric Cancer. 2005;8(2):86-94
15864715
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5675-9
8650150
Hum Genet. 2004 May;114(6):534-40
15007728
Am J Pathol. 2002 Aug;161(2):629-34
12163387
EMBO J. 2003 Aug 15;22(16):4103-10
12912909
Int J Cancer. 2008 Feb 1;122(3):603-8
17943730
EMBO Rep. 2002 May;3(5):420-5
11991946
Mol Carcinog. 2005 Jul;43(3):141-54
15937959
Cancer Res. 2008 Apr 15;68(8):2813-9
18413749
J Cell Physiol. 2002 Apr;191(1):42-50
11920680
Nat Genet. 1999 Feb;21(2):163-7
9988266
Int J Cancer. 1998 Dec 9;78(6):766-74
9833771
Mol Biol Evol. 2002 Apr;19(4):416-21
11919282
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
8790415
Carcinogenesis. 2003 Jan;24(1):17-24
12538344
Oncogene. 2004 Oct 21;23(49):8171-83
15377994
Mol Cancer. 2008 Jan 24;7:11
18218118
J Biol Chem. 2002 May 31;277(22):19538-45
11893755
Nat Genet. 2000 Dec;26(4):435-9
11101840
Cancer Res. 2005 Mar 1;65(5):1642-6
15753357
Cancer Res. 2004 May 1;64(9):3137-43
15126351
Cancer Lett. 2007 Mar 8;247(1):56-71
16644104
Mol Cancer Res. 2005 Mar;3(3):119-29
15798092
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):982-7
16415157
Cancer Res. 2007 Nov 15;67(22):10859-68
18006831
Cancer Res. 2006 Feb 15;66(4):2116-28
16489012
Hum Mol Genet. 2002 Sep 15;11(19):2201-6
12217948
Respir Physiol Neurobiol. 2004 Dec 15;144(2-3):141-59
15556098
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6203-7
15448008
Cancer Res. 2003 Apr 15;63(8):1927-35
12702585
Cancer Res. 2004 Dec 15;64(24):9027-34
15604268
Oncogene. 2002 Sep 12;21(41):6395-402
12214281
Lab Invest. 2004 Jan;84(1):91-101
14647402
J Biol Chem. 2004 Feb 27;279(9):8063-9
14660570